Breast implants are medical devices implanted under the breast tissue or chest muscle to increase breast size (augmentation) or to replace breast tissue that has been removed due to cancer or that has failed to develop properly due to severe breast abnormality (reconstruction). They are also used in revision surgeries to correct or improve the result of an original surgery. There are two types of breast implants approved in the U.S., which includes saline filled and silicone gel filled, both the types have a silicone outer shell that vary in size, shell thickness, shell surface texture, and shape.
Increasing awareness of breast reconstruction procedure has led to higher number of women opting for mastectomy procedure. Moreover, raising awareness of women towards breast augmentation procedures for beauty enhancement has resulted in higher breast implant procedures.
According to American Society of Plastic Surgeons, 193,073 breast augmentation surgeries were performed in U.S
Market Dynamics
The increasing prevalence of breast cancer, rising research and development activities for the development of novel breast implants, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global breast implants market over the forecast period.
For instance, according to breast cancer organization, in 2021, an estimated 281,550 new cases of invasive breast cancer were expected to be diagnosed in women in the U.S, along with 49,290 new cases of non-invasive breast cancer.
Key features of the study:
- This report provides an in-depth analysis of the global breast implants market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global breast implants market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Abbvie, Inc, CEREPLAS, Establishment Labs S.A., GC Aesthetics, GROUPE SEBBIN SAS, Guangzhou Wanhe Plastic Materials Co., Ltd., HansBiomed Co., Ltd, Ideal Implant Inc, Laboratoires Anios, Mentor Worldwide LLC, Polytech Health & Aesthetics GmbH, Shanghai Kangning Medical Device Co., Ltd, Sientra, Inc, and Silimed
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global breast implants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global breast implants market
Detailed Segmentation:
- Global Breast Implants Market, By Product Type:
- Saline Implant
- Silicone Implant
- Global Breast Implants Market, By Shape:
- Global Breast Implants Market, By Application:
- Breast Augmentation
- Breast Reconstruction
- Global Breast Implants Market, By Texture:
- Global Breast Implants Market, By End User:
- Global Breast Implants Market, By Region:
- North America
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Abbvie, Inc.*
- Company Overview
- Material Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- CEREPLAS
- Establishment Labs S.A
- GC Aesthetics
- GROUPE SEBBIN SAS
- Guangzhou Wanhe Plastic Materials Co., Ltd.
- HansBiomed Co., Ltd
- Ideal Implant Inc
- Laboratoires Anios
- Mentor Worldwide LLC
- Polytech Health & Aesthetics GmbH
- Shanghai Kangning Medical Device Co., Ltd
- Sientra, Inc
- Silimed
“*” marked represents similar segmentation in other categories in the respective section.
